1. Search Result
Search Result
Results for "

EGFR domain I

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Peptides

2

Inhibitory Antibodies

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-153268
    Silevertinib
    2 Publications Verification

    BDTX-1535; EGFR-IN-76

    EGFR Infection Neurological Disease Metabolic Disease Cancer
    Silevertinib (BDTX-1535) is an irreversible, brain-penetrant, selective and orally active EGFR inhibitor with wild-type EGFR-sparing. Silevertinib targets key EGFR resistance mutations, including the kinase domain (C797S, L718Q, G724S, S768I), extracellular domain (EGFRvIII, A289X), and EGFR amplification. Silevertinib exerts anti-tumor activity with well tolerated in vivo. Silevertinib can be used for non-small cell lung cancer (NSCLC) and glioblastoma (GBM) research .
    Silevertinib
  • HY-P991783

    EGFR Cancer
    Anti-Mouse EGFR (domain I) Antibody (EMab-300) reacts with domain I of the mouse EGFR. Anti-Mouse EGFR (domain I) Antibody (EMab-300) applies to the detection of mouse EGFR using flow cytometry. Recommend Isotype Controls: Rat IgG1 kappa, Isotype Control (HY-P99979) .
    Anti-Mouse EGFR (domain I) Antibody (EMab-300)
  • HY-P11752

    EGFR Cancer
    Cyclo (KLARLLT) is an EGFR ligand with a Kd value of 1.16 μM. Cyclo (KLARLLT) binds to domain I of EGFR and interacts with both the open and closed conformations of EGFR. Cyclo (KLARLLT) is a modified variant of LARLLT (HY-P11078). Cyclo (KLARLLT) can be used in the research of colorectal cancer .
    Cyclo(KLARLLT)
  • HY-P991780

    EGFR Cancer
    Anti-Mouse HER2 (domain I) Antibody (H2Mab-304) reacts with domain I of mouse HER2. HER2 is a 185 kDa transmembrane receptor tyrosine kinase that is part of the EGFR family. Recommend Isotype Controls: Rat IgG1 kappa, Isotype Control (HY-P99979).
    Anti-Mouse HER2 (domain I) Antibody (H2Mab-304)
  • HY-P11757

    EGFR Cancer
    Cyclo[K(N3)larllt] is a seven-membered cyclic peptide targeting EGFR, with a Kd value of 5.09 μM, and exhibits binding selectivity toward homologous proteins HER2 and HER3. Cyclo[K(N3)larllt] has no cytotoxicity and shows no growth inhibitory effect on cancer cells overexpressing EGFR. Cyclo[K(N3)larllt] can serve as a ligand for EGFR-targeted fluorescent conjugates, which is applicable to the detection of cancers with EGFR overexpression. Cyclo[K(N3)larllt] can be used in the research of colorectal cancer .
    Cyclo[K(N3)larllt]

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: